338 related articles for article (PubMed ID: 22355097)
1. Metformin in cancer: translational challenges.
Dowling RJ; Niraula S; Stambolic V; Goodwin PJ
J Mol Endocrinol; 2012 Jun; 48(3):R31-43. PubMed ID: 22355097
[TBL] [Abstract][Full Text] [Related]
2. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
3. New perspective for an old antidiabetic drug: metformin as anticancer agent.
Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
5. Metformin and cancer therapy.
Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
[TBL] [Abstract][Full Text] [Related]
6. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
7. Metformin as an antitumor agent in cancer prevention and treatment.
Li D
J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
[TBL] [Abstract][Full Text] [Related]
9. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.
Pierotti MA; Berrino F; Gariboldi M; Melani C; Mogavero A; Negri T; Pasanisi P; Pilotti S
Oncogene; 2013 Mar; 32(12):1475-87. PubMed ID: 22665053
[TBL] [Abstract][Full Text] [Related]
10. Cancer-drug induced insulin resistance: innocent bystander or unusual suspect.
Ariaans G; de Jong S; Gietema JA; Lefrandt JD; de Vries EG; Jalving M
Cancer Treat Rev; 2015 Apr; 41(4):376-84. PubMed ID: 25724262
[TBL] [Abstract][Full Text] [Related]
11. Metformin: an old drug with new potential.
Hajjar J; Habra MA; Naing A
Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
[TBL] [Abstract][Full Text] [Related]
12. Metformin, cancer and glucose metabolism.
Salani B; Del Rio A; Marini C; Sambuceti G; Cordera R; Maggi D
Endocr Relat Cancer; 2014; 21(6):R461-71. PubMed ID: 25273809
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
14. Understanding the benefit of metformin use in cancer treatment.
Dowling RJ; Goodwin PJ; Stambolic V
BMC Med; 2011 Apr; 9():33. PubMed ID: 21470407
[TBL] [Abstract][Full Text] [Related]
15. The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact.
Phielix E; Szendroedi J; Roden M
Trends Pharmacol Sci; 2011 Oct; 32(10):607-16. PubMed ID: 21824668
[TBL] [Abstract][Full Text] [Related]
16. Investigating metformin for cancer prevention and treatment: the end of the beginning.
Pollak MN
Cancer Discov; 2012 Sep; 2(9):778-90. PubMed ID: 22926251
[TBL] [Abstract][Full Text] [Related]
17. Metformin and Prostate Cancer: a New Role for an Old Drug.
Whitburn J; Edwards CM; Sooriakumaran P
Curr Urol Rep; 2017 Jun; 18(6):46. PubMed ID: 28444639
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
Gallagher EJ; LeRoith D
Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
[TBL] [Abstract][Full Text] [Related]
19. IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer.
Dool CJ; Mashhedi H; Zakikhani M; David S; Zhao Y; Birman E; Carboni JM; Gottardis M; Blouin MJ; Pollak M
Endocr Relat Cancer; 2011 Dec; 18(6):699-709. PubMed ID: 21946410
[TBL] [Abstract][Full Text] [Related]
20. [Advances of the anti-tumor research of metformin].
Xue CJ; Liu KX
Yao Xue Xue Bao; 2015 Oct; 50(10):1210-6. PubMed ID: 26837164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
